Advertisement

Entzündliche Erkrankungen

  • E. Schmutzhard
  • R. Kaiser
  • U. Meyding-Lamadé
  • G. Arendt
  • T. Nolting
  • M. Maschke
  • I. Zerr
Chapter
  • 10k Downloads

Zusammenfassung

Unter einer Meningitis versteht man eine Entzündung von Pia mater und Arachnoidea. Das Erregerspektrum ist weit und reicht von Bakterien, die hämatogen-metastatisch, fortgeleitet oder durch offene Hirnverletzung zur eitrigen Meningitis führen, über Viren zu Pilzen und Parasiten. Insbesondere bei den unbehandelt häufig letal verlaufenden eitrigen Meningitiden ist eine rasche Diagnose mit Erregernachweis notwendig. Unverzüglich ist daraufhin eine spezifische, der regionalen Resistenzentwicklung angepasste Therapie einzuleiten. Die meningeale Affektion im Rahmen einer Listeriose oder Tuberkulose verdient aufgrund des klinischen Bildes, des Verlaufs und der spezifischen Therapie besondere Beachtung. Die fungalen Infektionen werden, da klinisch häufig als Meningoenzephalitis imponierend, in Abschn. 33.3 abgehandelt.

Literatur

Zitierte Literatur

  1. Ackermann R, Rehse-Kupper B, Gollmer E (1987) Progressive Borrelia encephalomyelitis. Zentralbl Bakteriol Mikrobiol Hyg [A] 263: 297–300Google Scholar
  2. Alitalo A, Meri T, Lankinen H et al. (2002) Complement inhibitor factor H binding to Lyme disease spirochetes is mediated by inducible expression of multiple plasmid-encoded outer surface protein E paralogs. J Immunol 169: 3847–3853PubMedGoogle Scholar
  3. Alkadhi H, Kollias SS (2000) MRI in tick-borne encephalitis. Neuroradiology 42(10): 753–755PubMedCrossRefGoogle Scholar
  4. Anderson JF (1988) Mammalian and avian reservoirs for Borrelia burgdorferi. Ann N Y Acad Sci 539: 180–191PubMedCrossRefGoogle Scholar
  5. Antinori A, Arendt G, Becker JT et al. (2007) Updated research nosology for HIV-associated neurocognitive disorders. Neurology 69(18): 1789–1799PubMedCrossRefGoogle Scholar
  6. Arav-Boger R, Crawford T, Steere AC, Halsey NA (2002) Cerebellar ataxia as the presenting manifestation of Lyme disease. Pediatr Infect Dis J 21: 353–356PubMedCrossRefGoogle Scholar
  7. Arendt G, Nolting T, Frisch C et al. (2007) Intrathecal viral replication and cerebral deficits in different stages of human immunodeficiency virus disease. J Neurovirol 13(3): 225–232PubMedCrossRefGoogle Scholar
  8. Baig S, Olsson T, Hojeberg B, Link H (1991) Cells secreting antibodies to myelin basic protein in cerebrospinal fluid of patients with Lyme neuroborreliosis. Neurology 41: 581–587PubMedGoogle Scholar
  9. Barret A, Tagliavini F, Forloni G et al. (2003) Evaluation of quinacrine treatment for prion diseases. J Virol 77: 8462–8469PubMedCrossRefGoogle Scholar
  10. Baxter Deutschland GmbH (2010) Risikogebiete in Europa. http://www.ze-cken.de. Gesehen 12 Apr 2010
  11. Bernardino AL, Myers TA, Alvarez X, Hasegawa A, Philipp MT (2008) Toll-like receptors: Insights into their possible role in the pathogenesis of lyme neuroborreliosis. Infect Immun 76: 4385–4395PubMedCrossRefGoogle Scholar
  12. Bossart KN, Zhu Z, Middleton D et al. (2009) A neutralizing human monoclonal antibody protects against lethal disease in a new ferret model of acute nipah virus infection. Plos Pathog 5(10): e1000642PubMedCrossRefGoogle Scholar
  13. Brandel JP, Delasnerie-Laupretre N, Laplanche JL, Hauw JJ, Alperovitch A (2000) Diagnosis of Creutzfeldt-Jakob disease: Effect of clinical criteria on incidence estimates. Neurology 54: 1095–1099PubMedGoogle Scholar
  14. Brannagan TH 3rd, Zhou Y (2003) HIV-associated Guillain-Barre syndrome. J Neurol Sci 208(1–2): 39–42PubMedCrossRefGoogle Scholar
  15. Brettschneider S, Bruckbauer H, Klugbauer N, Hofmann H (1998) Diagnostic value of PCR for detection of Borrelia burgdorferi in skin biopsy and urine samples from patients with skin borreliosis. J Clin Microbiol 36: 2658–2665PubMedGoogle Scholar
  16. Brew BJ, Crowe SM, Landay A, Cysique LA, Guillemin G (2009) Neurodegeneration and ageing in the HAART era. J Neuroimmune Pharmacol 4(2): 163–174PubMedCrossRefGoogle Scholar
  17. Brogan GX, Homan CS, Viccellio P (1990) The enlarging clinical spectrum of Lyme disease: Lyme cerebral vasculitis, a new disease entity. Ann Emerg Med 19: 572–576PubMedCrossRefGoogle Scholar
  18. Brorson O, Brorson SH (1997) Transformation of cystic forms of Borrelia burgdorferi to normal, mobile spirochetes. Infection 25: 240–246PubMedCrossRefGoogle Scholar
  19. Brown P, Preece M, Brandel J-P et al. (2000) Iatrogenic Creutzfeldt-Jakob disease at the millennium. Neurology 55: 1075–1081PubMedGoogle Scholar
  20. Bruckbauer HR, Preac MV, Herzer P, Hofmann H (1997) Sudeck’s atrophy in Lyme borreliosis. Infection 25: 372–376PubMedCrossRefGoogle Scholar
  21. Bujak DI, Weinstein A, Dornbush RL (1996) Clinical and neurocognitive features of the post Lyme syndrome. J Rheumatol 23: 1392–1397PubMedGoogle Scholar
  22. Bunikis J, Barbour AG (2002) Laboratory testing for suspected Lyme disease. Med Clin North Am 86: 311–340PubMedCrossRefGoogle Scholar
  23. Burgdorfer W, Lane RS, Barbour AG, Gresbrink RA, Anderson JR (1985) The western black-legged tick, Ixodes pacificus: A vector of Borrelia burgdorferi. Am JTrop Med Hyg 34: 925–930Google Scholar
  24. Carod AF, Perez L, Gracia NM, Giron MJ. (1994) Fracasodel tratamiento empirico con ceftriaxona en la enfermedad de la motoneurona. Neurologia 9: 29–31Google Scholar
  25. Casjens S (2000) Borrelia genomes in the year 2000. J Mol Microbiol Biotechnol 2: 401–410PubMedGoogle Scholar
  26. Cassarino DS, Quezado MM, Ghatak NR, Duray PH (2003) Lyme-associated parkinsonism: A neuropathologic case study and review of the literature. Arch Pathol Lab Med 127: 1204–1206PubMedGoogle Scholar
  27. Chadha MS, Comer JA, Lowe L et al.(2006) Nipah virus-associated encephalitis outbreak, Siliguri, India. Emerg Infect Dis 12(2): 235–240PubMedGoogle Scholar
  28. Charrel RN, Lamballerie de X, Raoult D (2007) Chikungunya outbreaks – the globalization of vectorborne diseases. N Engl J Med 356(8): 769–771PubMedCrossRefGoogle Scholar
  29. Chiarini LB, Freitas AR, Zanata SM, Berntani RR, Martins VR, Linden R (2002) Cellular prion protein transduces neuroprotective signals. Embo J 13: 3317–3326CrossRefGoogle Scholar
  30. Christen HJ (1996) Lyme neuroborreliosis in children. Ann Med 28: 235–240PubMedCrossRefGoogle Scholar
  31. Ciampi de Andrade D, Jean S, Clavelou P, Dallel R, Bouhassira D (2010) Chronic pain associated with the Chikungunya Fever: Long lasting burden of an acute illness. BMC Infect Dis 10(1): 31 [Epub ahead of print]CrossRefGoogle Scholar
  32. Corssmit EP, Leverstein-van Hall MA, Portegies P, Bakker P (1997) Severe neurological complications in association with Epstein-Barr virus infection. J Neurovirol 3: 460–464PubMedCrossRefGoogle Scholar
  33. Coyle PK (2000) Chronic meningitis. Curr Treat Options Neurol 2(4): 375–387PubMedCrossRefGoogle Scholar
  34. Curless RG, Schatz NJ, Bowen BC, Rodriguez Z, Ruiz A (1996) Lyme neuroborreliosis masquerading as a brainstem tumor in a 15-year-old. Pediatr Neurol 15: 258–260PubMedCrossRefGoogle Scholar
  35. Dai Z, Lackland H, Stein S et al. (1993) Molecular mimicry in Lyme disease: Monoclonal antibody H9724 to B. burgdorferi flagellin specifically detects chaperonin-HSP60. Biochim Biophys Acta 1181: 97–100PubMedGoogle Scholar
  36. De Luigi A, Colombo L, Diomede L et al. (2008) The efficacy of tetracyclines in peripheral and intracerebral prion infection. PLoS ONE 3: e1888PubMedCrossRefGoogle Scholar
  37. Diener HC, Putzki N et al. (2008) Leitlinien für Diagnostik und Therapie in der Neurologie, 4. Aufl. Thieme, StuttgartGoogle Scholar
  38. Diringer MN, Halperin JJ, Dattwyler RJ (1987) Lyme meningoencephalitis: Report of a severe, penicillin-resistant case. Arthritis Rheum 30: 705–708PubMedGoogle Scholar
  39. Dore GJ, Li Y, McDonald A, Ree H, Kaldor JM (2002) Impact of highly active antiretroviral therapy on individual AIDS-defining illness incidence and survival in Australia. J Acquir Immune Defic Syndr 29(4): 388–395PubMedGoogle Scholar
  40. Dotevall L, Hagberg L (1999) Successful oral doxycycline treatment of Lyme disease-associated facial palsy and meningitis. Clin Infect Dis 28: 569–574PubMedCrossRefGoogle Scholar
  41. Dotevall L, Hagberg L. Penetration of doxycycline into cerebrospinal fluid in patients treated for suspected Lyme neuroborreliosis. Antimicrob Agents Chemother 33: 1078–1080Google Scholar
  42. Ecker M, Allison SL, Meixner T, Heinz FX (1999) Sequence analysis and genetic classification of tick-borne encephalitis viruses from Europe and Asia. J Gen Virol 80 (Pt 1): 179–185PubMedGoogle Scholar
  43. Elkins LE, Pollina DA, Scheffer SR, Krupp LB (1999) Psychological states and neuropsychological performances in chronic Lyme disease. Appl Neuropsychol 6: 19–26PubMedCrossRefGoogle Scholar
  44. Fauser S, Stich O, Rauer S (2007) Unusual case of tick borne encephalitis with isolated myeloradiculitis. J Neurol Neurosurg Psychiatry 78: 909–910PubMedCrossRefGoogle Scholar
  45. Fikrig E, Berland R, Chen M, Williams S, Sigal LH, Flavell RA (19993) Serologic response to the Borrelia burgdorferi flagellin demonstrates an epitope common to a neuroblastoma cell line. 90: 183–187Google Scholar
  46. Fingerle V, Schulte-Spechtel UC, Ruzic-Sabljic E et al. (2008) Epidemiological aspects and molecular characterization of Borrelia burgdorferi s.l. from southern Germany with special respect to the new species Borrelia spielmanii sp. nov. Int J Med Microbiol 298: 279–290PubMedCrossRefGoogle Scholar
  47. Finizia C, Jonsson R, Hanner P (2001) Serum and cerebrospinal fluid pathology in patients with sudden sensorineural hearing loss. Acta Otolaryngol 121: 823–830PubMedCrossRefGoogle Scholar
  48. Finkenstaedt M, Szudra A, Zerr I et al. (1996) MR imaging of Creutzfeldt-Jakob disease. Radiology 199: 793–798PubMedGoogle Scholar
  49. Forloni G, Iussich S, Awan T et al. (2202) Tetracyclines affect prion infectivity. Proc Natl Acad Sci 99: 10849–10854CrossRefGoogle Scholar
  50. Fraser CM, Casjens S, Huang WM et al. (1997) Genomic sequence of a Lyme disease spirochaete, Borrelia burgdorferi. Nature 390: 580–586PubMedCrossRefGoogle Scholar
  51. Fraser DD, Kong LI, Miller FW (1992) Molecular detection of persistent Borrelia burgdorferi in a man with dermatomyositis. Clin Exp Rheumatol 10: 387–390PubMedGoogle Scholar
  52. Fredrikson S, Link H (1988) CNS-borreliosis selectively affecting central motor neurons. Acta Neurol Scand 78: 181–184PubMedCrossRefGoogle Scholar
  53. Freiberg AN, Worthy MN, Lee B, Holbrook MR (2010) Combined chloroquine and ribavirin treatment does not prevent death in a hamster model of Nipah and Hendra virus infection. J Gen Virol 91(Pt 3): 765–772PubMedCrossRefGoogle Scholar
  54. Frese A, Luttmann RJ, Husstedt IW, Ringelstein EB, Evers S (2002) Geniculate neuralgia as a manifestation of neuroborreliosis. Headache 42: 826–828PubMedCrossRefGoogle Scholar
  55. Gambetti P, Kong Q, Zou W, Parchi P, Chen S (2003) Sporadic and familial CJD: Classification and characterisation. Br Med Bull 66: 213–239PubMedCrossRefGoogle Scholar
  56. Gmitterová K, Heinemnann U, Bodemer M, Krasnianski A, Meissner B, Kretzschmar HA, Zerr I (2009) 14-3-3 CSF levels in sporadic Creutzfeldt-Jakob disease differ across molecular subtypes. Neurobiol Aging 30: 1842–1850PubMedCrossRefGoogle Scholar
  57. Goudsmit J, Wolf F de, Paul DA et al. (1986) Expression of human immunodeficiency virus antigen (HIV-Ag) in serum and cerebrospinal fluid during acute and chronic infection. Lancet 2(8500): 177–180PubMedCrossRefGoogle Scholar
  58. Green A, Sanchez-Juan P, Ladogana A et al. (2007) CSF analysis in patients with sporadic CJD and other transmissible spongiform encephalopathies. Eur J Neurol 14: 121–124PubMedCrossRefGoogle Scholar
  59. Gunther G, Haglund M, Lindquist L, Forsgren M, Skoldenberg B (1997) Tickbone encephalitis in Sweden in relation to aseptic meningo-encephalitis of other etiology: A prospective study of clinical course and outcome. J Neurol 244: 230–238PubMedCrossRefGoogle Scholar
  60. Gurley ES, Montgomery JM, Hossain MJ et al. (2007) Person-to-person transmission of Nipah virus in Bangladeshi community. Emerg Infect Dis 13(7): 1031–1037PubMedGoogle Scholar
  61. Gustaw K, Beltowska K, Studzinska MM (2001) Neurological and psychological symptoms after the severe acute neuroborreliosis. Ann Agric Environ Med 8: 91–94PubMedGoogle Scholar
  62. Gutacker M, Valsangiacomo C, Balmelli T, Bernasconi MV, Bouras C, Piffaretti JC (1998) Arguments against the involvement of Borrelia burgdorferi sensu lato in Alzheimer’s disease. Res Microbiol 149: 31–37PubMedCrossRefGoogle Scholar
  63. Habek M, Mubrin Z, Brinar VV (2007) Avellis syndrome due to borreliosis. Eur J Neurol 14: 112–114PubMedCrossRefGoogle Scholar
  64. Haglund M, Forsgren M, Lindh G, Lindquist L (1996) A 10-year follow-up study of tick-borne encephalitis in the Stockholm area and a review of the literature: Need for a vaccination strategy. Scand J Infect Dis 28: 217–224PubMedCrossRefGoogle Scholar
  65. Halperin JJ, Kaplan GP, Brazinsky S et al. (1990) Immunologic reactivity against Borrelia burgdorferi in patients with motor neuron disease. Arch Neurol 47: 586–594PubMedGoogle Scholar
  66. Halperin JJ, Shapiro ED, Logigian E et al. (2007) Practice parameter: Treatment of nervous system Lyme disease (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 69: 91–102PubMedCrossRefGoogle Scholar
  67. Halpin K, Young PL, Field HE, Mackenzie JS (2000) Isolation of Hendra virus from pteropid bats: A natural reservoir of Hendra virus. J General Virol 81(8): 1927–1932Google Scholar
  68. Hammers-Berggren S, Grondahl A, Karlsson M, Arbin M von, Carlsson A, Stiernstedt G (1993a) Screening for neuroborreliosis in patients with stroke. Stroke 24: 1393–1396CrossRefGoogle Scholar
  69. Hammers-Berggren S, Hansen K, Lebech AM, Karlsson M (1993b) Borrelia burgdorferi-specific intrathecal antibody production in neuroborreliosis: A follow-up study. Neurology 43: 169–175Google Scholar
  70. Hansel Y, Ackerl M, Stanek G (1995) ALS-ähnlicher Krankheitsverlauf bei chronischer Neuroborreliose. Wien Med Wochenschr 145: 186–188PubMedGoogle Scholar
  71. Hardon WJ, Bernsen HJ, Nouhuys-Leenders J, Mulder B (2002) Internuclear ophthalmoplegia as the first sign of neuroborreliosis. J Neurol 249: 1119–1120PubMedCrossRefGoogle Scholar
  72. Hauser U, Lehnert G, Wilske B (1999) Validity of interpretation criteria for standardized Western blots (immunoblots) for serodiagnosis of Lyme borreliosis based on sera collected throughout Europe. J Clin Microbiol 37: 2241–2247PubMedGoogle Scholar
  73. Heinemann U, Gloeckner F, Varges D, Meissner B, Krasnianski A, Zerr I (2007a) Differenzialdiagnose rasch progredienter Demenzen. Z Gerontopsychologie Psychiatrie 20: 17–26CrossRefGoogle Scholar
  74. Heinemann U, Krasnianski A, Meissner B et al. (2007b) Creutzfeldt-Jakob disease in Germany: A prospective 12-year surveillance. Brain 130: 1350–1359CrossRefGoogle Scholar
  75. Heinz FX, Mandl CW (1993) The molecular biology of tick-borne encephalitis virus. Review article. APMIS 101: 735–745PubMedCrossRefGoogle Scholar
  76. Hemmer B, Glocker FX, Kaiser R, Lucking CH, Deuschl G (1997) Generalised motor neuron disease as an unusual manifestation of Borrelia burgdorferi infection. J Neurol Neurosurg Psychiatry 63: 257–258PubMedCrossRefGoogle Scholar
  77. Hill A, Zeidler M, Ironside J, Collinge J (1997) Diagnosis of new variant Creutzfeldt-Jakob disease by tonsil biopsy. Lancet 349: 99–100PubMedCrossRefGoogle Scholar
  78. Hilton E, Tramontano A, DeVoti J, Sood SK (1997) Temporal study of immunoglobin M seroreactivity to Borrelia burgdorferi in patients treated for Lyme borreliosis. J Clin Microbiol 35: 774–776PubMedGoogle Scholar
  79. Hiraga A, Kuwabara S, Nakamura A, Yuki N, Hattori T, Matsunaga T (2007) Fisher/Gullain-Barre overlap syndrome in advanced AIDS. J Neurol Sci 258(1–2): 148–150PubMedCrossRefGoogle Scholar
  80. Hoffmann JC, Stichtenoth DO, Zeidler H et al. (1995) Lyme disease in a 74-year-old forest owner with symptoms of dermatomyositis. Arthritis Rheum 38: 1157–1160PubMedCrossRefGoogle Scholar
  81. Holmgren AR, Matteson EL (2006) Lyme myositis. Arthritis Rheum 54: 2697–2700PubMedCrossRefGoogle Scholar
  82. Holzmann H (2003) Diagnosis of tick-borne encephalitis. Vaccine 21 (Suppl 1): S36-S40PubMedCrossRefGoogle Scholar
  83. Holzmann H, Vorobyova MS, Ladyzhenskaya IP et al. (1992) Molecular epidemiology of tick-borne encephalitis virus: Cross-protection between European and Far Eastern subtypes. Vaccine 10: 345–349PubMedCrossRefGoogle Scholar
  84. Horowitz HW, Sanghera K, Goldberg N et al. (1994) Dermatomyositis associated with Lyme disease: Case report and review of Lyme myositis. Clin Infect Dis 18: 166–171PubMedCrossRefGoogle Scholar
  85. Hsich G, Kenney K, Gibbs Jr. CJ, Lee KH, Harrington MG (1996) The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongifrom encephalopathies. N Engl J Med 335: 924–930PubMedCrossRefGoogle Scholar
  86. Hu WT, Willoughby RE, Dhonau H, Mack KJ (2007) Long-term follow-up after treatment of rabies by induction of coma. N Engl J Med 357: 945–946PubMedCrossRefGoogle Scholar
  87. Hyden D, Roberg M, Odkvist L (1995) Borreliosis as a cause of sudden deafness and vestibular neuritis in Sweden. Acta Otolaryngol Suppl 520 (Pt 2): 320–322PubMedCrossRefGoogle Scholar
  88. Iero I, Elia M, Cosentino FI et al. (2004) Isolated monolateral neurosensory hearing loss as a rare sign of neuroborreliosis. Neurol Sci 25: 30–33PubMedCrossRefGoogle Scholar
  89. Ilowite NT (1995) Muscle, reticuloendothelial, and late skin manifestations of Lyme disease. Am J Med 98: 63S–68SPubMedCrossRefGoogle Scholar
  90. Jacobi C, Arlt S, Reiber H, Westner I et al. (2005) Immunoglobulins and virusspecific antibodies in patients with Creutzfeldt-Jakob disease. Acta Neurol Scand 111: 185–190PubMedCrossRefGoogle Scholar
  91. Jacobi C, Schwark C, Kress B, Hug A, Storch-Hagenlocher B, Schwaninger M (2006) Subarachnoid hemorrhage due to Borrelia burgdorferi-associated vasculitis. Eur J Neurol 13: 536–538PubMedCrossRefGoogle Scholar
  92. Kaida K, Ariga T, Yu RK (2009) Antiganglioside antibodies and their pathophysiological effects on Guillain-Barre syndrome and related disorders – a review. Glycobiology 19(7): 676–692PubMedCrossRefGoogle Scholar
  93. Kaiser R (1994) Variable CSF findings in early and late Lyme neuroborreliosis: A follow-up study in 47 patients. J Neurol 242: 26–36PubMedCrossRefGoogle Scholar
  94. Kaiser R (1995) Intrathecal immune response in patients with neuroborreliosis: Specificity of antibodies for neuronal proteins. J Neurol 242: 319–325PubMedCrossRefGoogle Scholar
  95. Kaiser R (1998) Neuroborreliosis. J Neurol 245: 247–255PubMedCrossRefGoogle Scholar
  96. Kaiser R (1999) The clinical and epidemiological profile of tick-borne encephalitis in southern Germany 1994–98: A prospective study of 656 patients. Brain 122 (Pt 11): 2067–2078PubMedCrossRefGoogle Scholar
  97. Kaiser R (2000) False-negative serology in patients with neuroborreliosis and the value of employing of different borrelial strains in serological assays. J Med Microbiol 49(10): 911–915PubMedGoogle Scholar
  98. Kaiser R (2004) Clinical courses of acute and chronic neuroborreliosis following treatment with ceftriaxone. Nervenarzt 75: 553–557PubMedCrossRefGoogle Scholar
  99. Kaiser R, Lucking CH (1993) Intrathecal synthesis of specific antibodies in neuroborreliosis. Comparison of different ELISA techniques and calculation methods. J Neurol Sci 118: 64–72PubMedCrossRefGoogle Scholar
  100. Kallenberg K, Schulz-Schaeffer W, Jastrow U et al. (2006) Creutzfeldt-Jakob disease: Comparative analysis of MR imaging sequences. Am J Neuroradiol 27: 1459–1462PubMedGoogle Scholar
  101. Kaplan RF, Trevino RP, Johnson GM et al. (2003) Cognitive function in posttreatment Lyme disease: Do additional antibiotics help? Neurology 60: 1916–1922PubMedGoogle Scholar
  102. Karkkonen K, Stiernstedt SH, Karlsson M (2001) Follow-up of patients treated with oral doxycycline for Lyme neuroborreliosis. Scand J Infect Dis 33: 259–262PubMedCrossRefGoogle Scholar
  103. Keil R, Baron R, Kaiser R, Deuschl G (1997) Vaskulitische Verlaufsform einer Neuroborreliose mit Thalamusinfarkt. Nervenarzt 68: 339–341PubMedCrossRefGoogle Scholar
  104. Kenney K, Brechtel C Takahashi H, Kurohara K, Anderson P, Gibbs CJ Jr. (2000) An enzyme-linked immunosorbent assay to quantify 14-3-3 proteins in the cerebrospinal fluid of suspected Creutzfeldt-Jakob disease patients. Ann Neurol 48: 395–398PubMedCrossRefGoogle Scholar
  105. Kindstrand E, Nilsson BY, Hovmark A, Pirskanen R, Asbrink E (1997) Peripheral neuropathy in acrodermatitis chronica atrophicans – a late Borrelia manifestation. Acta Neurol Scand 95: 338–345PubMedCrossRefGoogle Scholar
  106. Kindstrand E, Nilsson BY, Hovmark A et al. (2000) Polyneuropathy in late Lyme borreliosis – a clinical, neurophysiological and morphological description. Acta Neurol Scand 101: 47–52PubMedCrossRefGoogle Scholar
  107. Klempner MS, Hu LT, Evans J et al. (2001) Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. N Engl J Med 345: 85–92PubMedCrossRefGoogle Scholar
  108. Klockmann U, Krivanec K, Stephenson JR, Hilfenhaus J (1991) Protection against European isolates of tick-borne encephalitis virus after vaccination with a new tick-borne encephalitis vaccine. Vaccine 9: 210–212PubMedCrossRefGoogle Scholar
  109. Kohler J, Thoden U (1987) Pain syndromes in tick-borne neuroborreliosis. Clinical aspects and differential diagnosis. Schmerz 1: 107–113PubMedCrossRefGoogle Scholar
  110. Kovács GG, Trabattoni G, Hainfellner JA, Ironside JW, Knight RS, Budka H (2002) Mutations of the prion protein gene phenotypic spectrum. J Neurol 249(11): 1567–1582PubMedCrossRefGoogle Scholar
  111. Kovács GG, Puopolo M, Ladogana A et al. (2005) Genetic prion disease: The EUROCJD experience. Hum Genet 118: 166–174PubMedCrossRefGoogle Scholar
  112. Kraiczy P, Hellwage J, Skerka C et al. (2003) Immune evasion of Borrelia burgdorferi: Mapping of a complement-inhibitor factor H-binding site of Bb-CRASP-3, a novel member of the Erp protein family. Eur J Immunol 33: 697–707PubMedCrossRefGoogle Scholar
  113. Krampitz HE (1986) In vivo isolation and maintenance of some wild strains of European hard tick spirochetes in mammalian and arthropod hosts. A parasitologist’s view. Zentralbl Bakteriol Mikrobiol Hyg [A] 263: 21–28Google Scholar
  114. Krasnianski A, Meissner B, Schulz-Schaeffer W et al. (2006a) Clinical features and diagnosis of the MM2 cortical subtype of sporadic Creutzfeldt-Jakob disease. Arch Neurol 63: 876–880CrossRefGoogle Scholar
  115. Krasnianski A, Schulz-Schaeffer WJ, Kallenberg K et al. (2006b) Clinical findings and diagnostic tests in the MV-2 subtype of sporadic CJD. Brain 129: 2288–2296CrossRefGoogle Scholar
  116. Krasnianski A, Von Ahsen N, Heinemann U et al. (2009) Increased frequency of positive family history of dementia in sporadic CJD. Neurobiol Aging 30: 615–621PubMedCrossRefGoogle Scholar
  117. Kristoferitsch W, Baumhackl U, Sluga E, Stanek G, Zeiler K (1987) High-dose penicillin therapy in meningopolyneuritis Garin-Bujadoux-Bannwarth. Clinical and cerebrospinal fluid data. Zentralbl Bakteriol Mikrobiol Hyg [A]263: 357–364Google Scholar
  118. Kruger H, Reuss K, Pulz M et al. (1989) Meningoradiculitis and encephalomyelitis due to Borrelia burgdorferi: A follow-up study of 72 patients over 27 years. J Neurol 236: 322–328PubMedCrossRefGoogle Scholar
  119. Krupp LB, Hyman LG, Grimson R et al. (2003) Study and treatment of post Lyme disease (STOP-LD): A randomized double masked clinical trial. Neurology 60: 1923–1930PubMedGoogle Scholar
  120. Kuntzer T, Bogousslavsky J, Miklossy J, Steck AJ, Janzer R, Regli F (1991) Borrelia rhombencephalomyelopathy. Arch Neurol 48: 832–836PubMedGoogle Scholar
  121. Ladogana A, Puopolo M, Croes EA et al. (2005) Mortality from Creutzfeldt-Jakob disease and related disorders in Europe, Australia, and Canada. Neurology 64: 1586–1591PubMedCrossRefGoogle Scholar
  122. Lammli B, Muller A, Ballmer PE (2000) Late sequelae of early summer meningoencephalitis. Schweiz Med Wochenschr 130: 909–915PubMedGoogle Scholar
  123. Lebech AM (2002) Polymerase chain reaction in diagnosis of Borrelia burgdorferi infections and studies on taxonomic classification. APMIS Suppl 1–40Google Scholar
  124. Lee KE, Umapathi T, Tan CB et al. (1999) The neurological manifestations of Nipah virus encephalitis, a novel paramyxovirus. Ann Neurol 46: 428–432PubMedCrossRefGoogle Scholar
  125. Leonova GN, Ternovoi VA, Pavlenko EV, Maistrovskaya OS, Protopopova EV, Loktev VB (2007) Evaluation of vaccine Encepur Adult for induction of human neutralizing antibodies against recent Far Eastern subtype strains of tick-borne encephalitis virus. Vaccine 25: 895–901PubMedCrossRefGoogle Scholar
  126. Letendre SL, Ellis RJ, Everall I, Ances B, Bharti A, McCutchan JA (2009) Neurologic complications of HIV disease and their treatment. Top HIV Med 17(2): 46–56PubMedGoogle Scholar
  127. Levine JF, Wilson ML, Spielman A (1985) Mice as reservoirs of the Lyme disease spirochete. Am J Trop Med Hyg 34: 355–360PubMedGoogle Scholar
  128. Ljostad U, Mygland A (2008) CSF B-lymphocyte chemoattractant (CXCL13) in the early diagnosis of acute Lyme neuroborreliosis. J Neurol 255: 732–737PubMedCrossRefGoogle Scholar
  129. Ljostad U, Skogvoll E, Eikeland R et al. (2008) Oral doxycycline versus intravenous ceftriaxone for European Lyme neuroborreliosis: A multicentre, non-inferiority, double-blind, randomised trial. Lancet Neurol 7: 690–695PubMedCrossRefGoogle Scholar
  130. Llewelyn CA, Hewitt PE, Knight RSG, Amar K, Cousens S, Mackenzie J, Will RG (2004) Possible transmission of variant Creutzfeld-Jakob disease by blood transfusion. Lancet 363: 417–421PubMedCrossRefGoogle Scholar
  131. Lock G, Berger G, Grobe H.(1989) Neuroborreliose: Progressive Encephalomyelitis mit cerebraler Vaskulitis. Monatsschr Kinderheilkd 137: 101–104PubMedGoogle Scholar
  132. Lorenzi MC, Bittar RS, Pedalini ME, Zerati F, Yoshinari NH, Bento RF (2003) Sudden deafness and Lyme disease. Laryngoscope 113: 312–315PubMedCrossRefGoogle Scholar
  133. Ludewigs H, Zuber C, Vana K, Nikles D, Zerr I, Weiss S (2007) Therapeutic approaches for prion disorders. Expert Rev Anti Infect Ther 5: 613–630PubMedCrossRefGoogle Scholar
  134. Ma Y, Weis JJ (1993) Borrelia burgdorferi outer surface lipoproteins OspA and OspB possess B-cell mitogenic and cytokine-stimulatory properties. Infect Immun 61: 3843–3853PubMedGoogle Scholar
  135. Magid D, Schwartz B, Craft J, Schwartz JS (1992) Prevention of Lyme disease after tick bites. A cost-effectiveness analysis. N Engl J Med 327: 534–541PubMedCrossRefGoogle Scholar
  136. Magnarelli LA, Lawrenz M, Norris SJ, Fikrig E (2002) Comparative reactivity of human sera to recombinant VlsE and other Borrelia burgdorferi antigens in class-specific enzyme-linked immunosorbent assays for Lyme borreliosis. J Med Microbiol 51: 649–655PubMedGoogle Scholar
  137. Maiwald M, Oehme R, March O et al. (1998) Transmission risk of Borrelia burgdorferi sensu lato from Ixodes ricinus ticks to humans in southwest Germany. Epidemiol Infect 121: 103–108PubMedCrossRefGoogle Scholar
  138. Mantienne C, Albucher JF, Catalaa I, Sevely A, Cognard C, Manelfe C (2001) MRI in Lyme disease of the spinal cord. Neuroradiology 43: 485–488PubMedCrossRefGoogle Scholar
  139. Marques AR, Weir SC, Fahle GA, Fischer SH (2000) Lack of evidence of Borrelia involvement in Alzheimer’s disease. J Infect Dis 182(3): 1006–1007PubMedCrossRefGoogle Scholar
  140. Martin R, Ortlauf J, Sticht-Groh V, Bogdahn U, Goldmann SF, Mertens HG (1988) Borrelia burgdorferi – specific and autoreactive T-cell lines from cerebrospinal fluid in Lyme radiculomyelitis. Ann Neurol 24: 509–516PubMedCrossRefGoogle Scholar
  141. Martin R, Meinck HM, Schulte-Mattler W, Ricker K, Mertens HG (1990) Borrelia burgdorferi myelitis presenting as a partial stiff man syndrome. J Neurol 237: 51–54PubMedCrossRefGoogle Scholar
  142. May EF, Jabbari B (1990) Stroke in neuroborreliosis. Stroke 21: 1232–1235PubMedCrossRefGoogle Scholar
  143. Mclennan NF, Brennan PM, McNeill A et al. (2004) Prion protein accumulation and neuroprotection in hypoxic brain damage. Am J Pathol 165: 227–235PubMedCrossRefGoogle Scholar
  144. Meer-Scherrer L, Chang LC, Adelson ME et al. (2006) Lyme disease associated with Alzheimer’s disease. Curr Microbiol 52: 330–332PubMedCrossRefGoogle Scholar
  145. Meier C, Grahmann F, Engelhardt A, Dumas M (1989) Peripheral nerve disorders in Lyme-Borreliosis. Nerve biopsy studies from eight cases. Acta Neuropathol (Berl) 79: 271–278CrossRefGoogle Scholar
  146. Meissner B, Westner I, Kallenberg K et al. (2005) Sporadic Creutzfeldt-Jakob disease: Clinical and diagnostic characteristics of the rare VV1 type. Neurology 65: 1544–1550PubMedCrossRefGoogle Scholar
  147. Meissner B, Kallenberg K, Sanchez-Juan P et al. (2009) MRI lesion profiles in sporadic Creutzfeldt-Jakob disease. Neurology 72: 1994–2001PubMedCrossRefGoogle Scholar
  148. Meyer RK, McKinley MP, Bowman KA, Braunfeld MB, Barry RA, Prusiner SB (1986) Separation and properties of cellular and scrapie prion proteins. Proc Natl Acad Sci U S A 83: 2310–2314PubMedCrossRefGoogle Scholar
  149. Mickiene A, Laiskonis A, Gunther G, Vene S, Lundkvist A, Lindquist L (2002) Tickborne encephalitis in an area of high endemicity in lithuania: Disease severity and long-term prognosis. Clin Infect Dis 35: 650–658PubMedCrossRefGoogle Scholar
  150. Miklossy J (2008) Chronic inflammation and amyloidogenesis in Alzheimer’s disease– role of Spirochetes. J Alzheimers Dis 13: 381–391PubMedGoogle Scholar
  151. Mollenhauer B, Serafin S, Zerr I et al. (2003) Diagnostic problems during late course in Creutzfeldt-Jakob disease. J Neurol 250: 629–630PubMedCrossRefGoogle Scholar
  152. Morgello S, Estanislao L, Simpson D et al. (2004) HIV-associated distal sensory polyneuropathy in the era of highly active antiretroviral therapy: The Manhattan HIV Brain Bank. Arch Neurol 61(4): 546–551PubMedCrossRefGoogle Scholar
  153. Moses JM, Riseberg RS, Mansbach JM (2003) Lyme disease presenting with persistent headache. Pediatrics 112: e477–e479PubMedCrossRefGoogle Scholar
  154. Muller-Felber W, Reimers CD, Koning J de, Fischer P, Pilz A, Pongratz DE (1993) Myositis in Lyme borreliosis: An immunohistochemical study of seven patients. J Neurol Sci 118: 207–212PubMedCrossRefGoogle Scholar
  155. Murdoch DM, Suchard MS, Venter WD et al. (2009) Polychromatic immunophenotypic characterization of T cell profiles among HIV-infected patients experiencing immune reconstitution inflammatory syndrome (IRIS). AIDS Res Ther 6: 16PubMedCrossRefGoogle Scholar
  156. Murray R, Morawetz R, Kepes J, el Gammal T, LeDoux M (1992) Lyme neuroborreliosis manifesting as an intracranial mass lesion. Neurosurgery 30: 769–773PubMedCrossRefGoogle Scholar
  157. Mygland A, Skarpaas T, Ljostad U (2006) Chronic polyneuropathy and Lyme disease. Eur J Neurol 13: 1213–1215PubMedCrossRefGoogle Scholar
  158. Neumann RA, Aberer E, Stanek G (1989) Evidence for spirochetal origin of Sudeck’s atrophy (algodystrophy, reflex sympathetic dystrophy). Arch Orthop Trauma Surg 108: 314–316PubMedCrossRefGoogle Scholar
  159. Oesch B, Westaway D, Walchli M et al. (1985) A cellular gene encodes scrapie PrP 27–30 protein. Cell 40: 735–746PubMedCrossRefGoogle Scholar
  160. Ogrinc K, Lotric-Furlan S, Maraspin V, Cimperman J, Ruzic-Sabljic E, Strle F (2002) Cerebrospinal fluid findings in patients with symptoms suggesting chronic Lyme borreliosis. Wien Klin Wochenschr 114: 535–538PubMedGoogle Scholar
  161. Oksi J, Nikoskelainen J, Hiekkanen H et al. (2007) Duration of antibiotic treatment in disseminated Lyme borreliosis: A double-blind, randomized, placebo-controlled, multicenter clinical study. Eur J Clin Microbiol Infect Dis 26: 571–581PubMedCrossRefGoogle Scholar
  162. Otto M, Cepek L, Ratzka P et al. (2004) Efficacy of flupirtine on cognitive function in patients with CJD: A double-blind study. Neurology 62: 714–718PubMedGoogle Scholar
  163. Owen F, Poulter M, Shah T et al. (1990) An in-frame insertion in the prion protein gene in familial Creutzfeldt-Jakob disease. Mol Brain Res 7: 273–276PubMedCrossRefGoogle Scholar
  164. Pappolla MA, Omar R, Saran B et al. (1989) Concurrent neuroborreliosis and Alzheimer‘s disease: Analysis of the evidence. Hum Pathol 20: 753–757PubMedCrossRefGoogle Scholar
  165. Parchi P, Gambetti P (1995) Human prion diseases. Neurodegeneration 4: 117–129CrossRefGoogle Scholar
  166. Parchi P, Castellani R, Capellari S et al. (1996) Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease. Ann Neurol 39: 767–778PubMedCrossRefGoogle Scholar
  167. Parchi P, Giese A, Capellari S et al. (1999) Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 46: 224–233PubMedCrossRefGoogle Scholar
  168. Parchi P, Strammiello R, Notari S et al. (2009) Incidence and spectrum of sporadic Creutzfeldt-Jacob disease variants with mixed phenotype and co-occurence of PrP(Sc) types: an updated classification. Acta Neuropathol 118: 659–671PubMedCrossRefGoogle Scholar
  169. Parkin ET, Watt NT, Hussain I et al. (2007) Cellular prion protein regulates beta-secretase cleavage of the Alzheimer’s amyloid precursor protein. Proc Natl Acad Sci 104: 11062–11067PubMedCrossRefGoogle Scholar
  170. Parola P, De Lamballerie X, Raoult D (2006) Novel chinkungunya virus variant in travelers returning from Indian Ocean islands. Emerg Infect Dis 12(10): 1493–1499PubMedGoogle Scholar
  171. Pavlovic D, Levic Z, Dmitrovic R et al. (1993) Rombencefalitis kao manifestacija neuroborelioze. Glas Srp Akad Nauka [Med] 1: 233–236Google Scholar
  172. Peden A, Head MW, Ritchie D, Bell JE, Ironside JW (2004) Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet 364: 527–529PubMedCrossRefGoogle Scholar
  173. Peltomaa M, Pyykko I, Seppala I, Viljanen M (1998) Lyme borreliosis – an unusual cause of vertigo. Auris Nasus Larynx 25: 233–242PubMedCrossRefGoogle Scholar
  174. Peltomaa M, Pyykko I, Sappala I, Viitanen L, Viljanen M (2000) Lyme borreliosis, an etiological factor in sensorineural hearing loss? Eur Arch Otorhinolaryngol 257 (6): 317–322PubMedCrossRefGoogle Scholar
  175. Peter L, Jung J, Tilikete C, Ryvlin P, Mauguiere F (2006) Opsoclonus-myoclonus as a manifestation of Lyme disease. J Neurol Neurosurg Psychiatry 77: 1090–1091PubMedCrossRefGoogle Scholar
  176. Pfister HW, Einhaupl KM, Wilske B, Preac-Mursic V (1987) Bannwarth’s syndrome and the enlarged neurological spectrum of arthropod-borne borreliosis. Zentralbl Bakteriol Mikrobiol Hyg [A] 263: 343–347Google Scholar
  177. Pfister HW, Preac-Mursic V, Wilske B, Einhaupl KM, Weinberger K (1989) Latent Lyme neuroborreliosis: Presence of Borrelia burgdorferi in the cerebrospinal fluid without concurrent inflammatory signs. Neurology 39: 1118–1120PubMedGoogle Scholar
  178. Pialoux G, Gauzere BA, Jaureguiberry S, Strobel M (2007) Chikungunya an epidemic arbovirosis. Lancet Infect Dis 7(5): 319–327PubMedCrossRefGoogle Scholar
  179. Piccolo I, Thiella G, Sterzi R, Colombo N, Defanti CA (1989) Chorea as a symptom of neuroborreliosis: A case study. Ital J Neurol Sci 19: 235–239CrossRefGoogle Scholar
  180. Piesman J (1993) Dynamics of Borrelia burgdorferi transmission by nymphal Ixodes dammini ticks. J Infect Dis 167: 1082–1085PubMedCrossRefGoogle Scholar
  181. Piesman J, Mather TN, Sinsky RJ, Spielman A (1987) Duration of tick attachment and Borrelia burgdorferi transmission. J Clin Microbiol 25: 557–558PubMedGoogle Scholar
  182. Pocchiari M, Poupolo M, Croes EA et al. (2004) Predictors of survival in sporadic Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies. Brain 10: 2348–2359CrossRefGoogle Scholar
  183. Poponnikova TV (2006) Specific clinical and epidemiological features of tickborne encephalitis in Western Siberia. Int J Med Microbiol 296 (Suppl 40): 59–62PubMedCrossRefGoogle Scholar
  184. Porcella SF, Schwan TG (2001) Borrelia burgdorferi and Treponema pallidum: A comparison of functional genomics, environmental adaptations, and pathogenic mechanisms. J Clin Invest 107: 651–656PubMedCrossRefGoogle Scholar
  185. Porcella SF, Fitzpatrick CA, Bono JL (2000) Expression and immunological analysis of the plasmid-borne mlp genes of Borrelia burgdorferi strain B31. Infect Immun 68 (9): 4992–5001PubMedCrossRefGoogle Scholar
  186. Poser S, Zerr I (2002) Klinik, Diagnostik und Therapiemöglichkeiten der menschlichen Prionerkrankungen. Internist 43: 731–737PubMedCrossRefGoogle Scholar
  187. Prusiner SB, Groth DF, Bolton DC, Kent SB, Hood LE (1984) Purification and structural studies of a major scrapie prion protein. Cell 38: 127–134PubMedCrossRefGoogle Scholar
  188. Quinn SJ, Boucher BJ, Booth JB (1997) Reversible sensorineural hearing loss in Lyme disease. J Laryngol Otol 111: 562–564PubMedCrossRefGoogle Scholar
  189. Ramamoorthy R, Philipp MT (1998) Differential expression of Borrelia burgdorferi proteins during growth in vitro. Infect Immun 66: 5119–5124PubMedGoogle Scholar
  190. Reik L (1991) Lyme disease and the nervous system. Thieme, New YorkGoogle Scholar
  191. Reimer B, Erbas B, Lobbichler K et al. (2002) Seroprevalence of Borrelia infection in occupational tick-exposed people in Bavaria (Germany). Int J Med Microbiol 291 (Suppl 33): 215PubMedCrossRefGoogle Scholar
  192. Reimers CD, Koning J de, Neubert U et al. (1993) Borrelia burgdorferi myositis: Report of eight patients. J Neurol 240: 278–283PubMedCrossRefGoogle Scholar
  193. Riechelmann H, Hauser R, Vogt A, Mann W (1990) Der Borrelien-Titer bei HNO-Erkrankungen. Laryngorhinootologie 69: 65–69PubMedCrossRefGoogle Scholar
  194. Roberg M, Forsberg P, Fryden A, Hederstedt B, Hyden D, Odkvist L (1994) Long-term findings in patients with facial palsy and antibodies against Borrelia burgdorferi. Scand J Infect Dis 26: 559–567PubMedCrossRefGoogle Scholar
  195. Romi F, Krakenes J, Aarli JA, Tysnes OB (2004) Neuroborreliosis with vasculitis causing stroke-like manifestations. Eur Neurol 51: 49–50PubMedCrossRefGoogle Scholar
  196. Rupprecht TA, Koedel U, Angele B, Fingerle V, Pfister HW (2006) Cytokine CXCL13 – a possible early CSF marker for neuroborreliosis. Nervenarzt 77: 470–473PubMedCrossRefGoogle Scholar
  197. Rupprecht TA, Elstner M, Weil S, Pfister HW (2008a) Autoimmune-mediated polyneuropathy triggered by borrelial infection? Muscle Nerve 37: 781–785CrossRefGoogle Scholar
  198. Rupprecht TA, Koedel U, Fingerle V, Pfister HW (2008b) The pathogenesis of lyme neuroborreliosis: From infection to inflammation. Mol Med 14: 205–212Google Scholar
  199. Salonen R, Rinne JO, Halonen P, Puusa A, Marttila R, Viljanen MK (1994) Lyme borreliosis associated with complete flaccid paraplegia. J Infect 28: 181–184PubMedCrossRefGoogle Scholar
  200. Sanchez-Juan P, Green A, Ladogana A et al. (2006) CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease. Neurology 67: 637–643PubMedCrossRefGoogle Scholar
  201. Sanchez-Juan P, Sanchez-Valle R, Green A et al. (2007) Influence of timing on CSF tests value for Creutzfeldt-Jakob disease diagnosis. J Neurol 254: 901–906PubMedCrossRefGoogle Scholar
  202. Schafers M, Neukirchen S, Toyka KV, Sommer C (2008) Diagnostic value of sural nerve biopsy in patients with suspected Borrelia neuropathy. J Peripher Nerv Syst 13: 81–91PubMedCrossRefGoogle Scholar
  203. Schluesener HJ, Martin R, Sticht-Groh V (1989) Autoimmunity in Lyme disease: Molecular cloning of antigens recognized by antibodies in the cerebrospinal fluid. Autoimmunity 2: 323–330PubMedCrossRefGoogle Scholar
  204. Schmiedel J, Gahn G, Kummer R von, Reichmann H (2004) Cerebral vasculitis with multiple infarcts caused by lyme disease. Cerebrovasc Dis 17: 79–81PubMedCrossRefGoogle Scholar
  205. Schmitt AB, Kuker W, Nacimiento W (1999) Neuroborreliose mit ausgepragter zerebraler Vaskulitis und multiplen Hirninfarkten. Nervenarzt 70: 167–171PubMedCrossRefGoogle Scholar
  206. Schmutzhard E, Willeit J, Gerstenbrand F (1986) Meningopolyneuritis Bannwarth with focal nodular myositis. A new aspect in Lyme borreliosis. Klin Wochenschr 64: 1204–1208PubMedCrossRefGoogle Scholar
  207. Schmutzhard E, Stanek G, Pletschette M et al. (1988) Infections following tickbites. Tick-borne encephalitis and Lyme borreliosis – a prospective epidemiological study from Tyrol. Infection 16: 269–272PubMedCrossRefGoogle Scholar
  208. Schoenfeld R, Araneo B, Ma Y, Yang LM, Weis JJ (1992) Demonstration of a Blymphocyte mitogen produced by the Lyme disease pathogen, Borrelia burgdorferi. Infect Immun 60: 455–464PubMedGoogle Scholar
  209. Schröter A, Zerr I, Henkel K, Tschampa HJ, Finkenstaedt M, Poser S (2000) Magnetic resonance imaging (MRI) in the clinical diagnosis of Creutzfeldt-Jakob disease. Arch Neurol 57: 1751–1757PubMedCrossRefGoogle Scholar
  210. Schulz-Schaeffer WJ, Tschoke S, Kranefuss N et al. (2000) The paraffin-embedded tissue blot detects PrP(Sc) early in the incubation time in prion diseases. Am J Pathol 156: 51–56PubMedCrossRefGoogle Scholar
  211. Shelburne SA 3rd, Hamill RJ (2003) The immune reconstitution inflammatory syndrome. AIDS Rev 5(2): 67–79PubMedGoogle Scholar
  212. Sheng R, Wang A, Liu X (1997) Lyme neuroborreliosis with acute meningitis as the presenting manifestation: Report of a case. Zhonghua Nei Ke Za Zhi 36: 21–24PubMedGoogle Scholar
  213. Shimizu T, Hayashi H, Tanabe H, Iguchi K (1990) Encephalomyelitis with elevated serum antibody against Borrelia burgdorferi. Rinsho Shinkeigaku 30: 314–316PubMedGoogle Scholar
  214. Sigal LH (1990) Molecular mimicry and Lyme borreliosis. Ann Neurol 28: 195–196PubMedCrossRefGoogle Scholar
  215. Sigal LH (1993) Cross-reactivity between Borrelia burgdorferi flagellin and a human axonal 64, 000 molecular weight protein. J Infect Dis 167: 1372–1378PubMedCrossRefGoogle Scholar
  216. Sigal LH, Tatum AH (1988) Lyme disease patients’ serum contains IgM antibodies to Borrelia burgdorferi that cross-react with neuronal antigens. Neurology 38: 1439–1442PubMedGoogle Scholar
  217. Skeie GO, Eldoen G, Skeie BS, Midgard R, Kristoffersen EK, Bindoff LA (2007) Opsoclonus myoclonus syndrome in two cases with neuroborreliosis. Eur J Neurol 14: e1-e2PubMedCrossRefGoogle Scholar
  218. Skogman BH, Croner S, Odkvist L (2003) Acute facial palsy in children – a 2-year follow-up study with focus on Lyme neuroborreliosis. Int J Pediatr Otorhinolaryngol 67: 597–602PubMedCrossRefGoogle Scholar
  219. Smith DM, Zarate S, Shao H et al. (2009) Pleocytosis is associated with disruption of HIV compartmentalization between blood and cerebral spinal fluid viral populations. Virology 385(1): 204–208PubMedCrossRefGoogle Scholar
  220. Souza MS de, Fikrig E, Smith AL, Flavell RA, Barthold SW (1992) Nonspecific proliferative responses of murine lymphocytes to Borrelia burgdorferi antigens. J Infect Dis 165: 471–478PubMedCrossRefGoogle Scholar
  221. Sparkes RS, Simon M, Cohn VH et al. (1986) Assignment of the human and mouse prion protein genes to homologous chromosomes. Proc Natl Acad Sci U S A 83: 7358–7362PubMedCrossRefGoogle Scholar
  222. Stanek G, Kahl O (1999) Chemoprophylaxis for Lyme borreliosis? Zentralbl Bakteriol 289: 655–665PubMedGoogle Scholar
  223. Stanek G, Strle F (2003) Lyme borreliosis. Lancet 362: 1639–1647PubMedCrossRefGoogle Scholar
  224. Stanek G, Pletschette M, Flamm H et al. (1988) European Lyme borreliosis. Ann N Y Acad Sci 539: 274–282PubMedCrossRefGoogle Scholar
  225. Stanek G, O‘Connell S, Cimmino M et al. (1996) European Union Concerted Action on Risk Assessment in Lyme Borreliosis: Clinical case definitions for Lyme borreliosis. Wien Klin Wochenschr 108: 741–747PubMedGoogle Scholar
  226. Stanek G, Fingerle V, Hunfeld KP, Jaulhac B, Kaiser R, Krause A et al. (2010) Lyme borreliosis: Clinical case definitions for diagnosis and management in Europe. Clin Microbiol Infect (in press)Google Scholar
  227. Stevenson B, Schwan TG, Rosa PA (1995b) Temperature-related differential expression of antigens in the Lyme disease spirochete, Borrelia burgdorferi. Infect Immun 63: 4535–4539Google Scholar
  228. Stricker RB, Winger EE (2001) Decreased CD57 lymphocyte subset in patients with chronic Lyme disease. Immunol Lett 76(1): 43–48PubMedCrossRefGoogle Scholar
  229. Suchanek G, Kristoferitsch W, Stanek G, Bernheimer H (1986) Anti-myelin antibodies in cerebrospinal fluid and serum of patients with meningopolyneuritis Garin-Bujadoux-Bannwarth and other neurological diseases. Zentralbl Bakteriol Mikrobiol Hyg [A ] 263: 160–168Google Scholar
  230. Suss J, Schrader C, Falk U, Wohanka N (2004) Tick-borne encephalitis (TBE) in Germany – epidemiological data, development of risk areas and virus prevalence in field-collected ticks and in ticks removed from humans. Int J Med Microbiol 293 (Suppl 37): 69–79PubMedGoogle Scholar
  231. Tagliavini F, Forloni G, Colombo L et al. (2000) Tetracycline affects abnormal properties of synthetic PrP peptides and PrPSc in vitro. J Mol Biol 300: 1309–1322PubMedCrossRefGoogle Scholar
  232. Tan CT, Goh KJ, Wong KT et al. (2002) Relapsed and late-onset Nipah encephalitis. Ann Neurol 51(6): 703–708PubMedCrossRefGoogle Scholar
  233. Tjernberg I, Schon T, Ernerudh J, Wistedt AC, Forsberg P, Eliasson I (2008) C6-peptide serology as diagnostic tool in neuroborreliosis. APMIS 116: 393–399PubMedCrossRefGoogle Scholar
  234. Trevitt CR, Collinge J (2006) A systematic review of prion therapeutics in experimental models. Brain 129: 2241–2265PubMedCrossRefGoogle Scholar
  235. Tullman MJ, Delman BN, Lublin FD, Weinberger J (2003) Magnetic resonance imaging of meningoradiculomyelitis in early disseminated Lyme disease. J Neuroimaging 13: 264–268PubMedGoogle Scholar
  236. Tyler KL (2004) Update on herpes simplex encephalitis. Rev Neurol Dis 1(4): 169–178PubMedGoogle Scholar
  237. Van Everbroeck B, Quoilin S, Boons J, Martin JJ, Cras P (2003) A prospective study of CSF markers in 250 patients with possible Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry 74: 1210–1214PubMedCrossRefGoogle Scholar
  238. Van Everbroeck B, Boons J, Cras P (2005) Cerebrospinal fluid biomarkers in Creutzfeldt-Jakob disease. Clin Neurol Neurosurg 107: 355–360PubMedCrossRefGoogle Scholar
  239. Vazquez M, Sparrow SS, Shapiro ED (2003) Long-term neuropsychologic and health outcomes of children with facial nerve palsy attributable to Lyme disease. Pediatrics 112: e93–e97PubMedCrossRefGoogle Scholar
  240. Verma A (2001) Epidemiology and clinical features of HIV-1 associated neuropathies. J Peripher Nerv Syst 6(1): 8–13PubMedCrossRefGoogle Scholar
  241. Vukelic D, Bozinovic D, Morovic M et al. (2000) Opsoclonus-myoclonus syndrome in a child with neuroborreliosis. J Infect 40(2): 189–191PubMedCrossRefGoogle Scholar
  242. Walther LE, Hentschel H, Oehme A, Gudziol H, Beleites E (2003) Lyme disease – a reason for sudden sensorineural hearing loss and vestibular neuronitis?. Laryngorhinootologie 82: 249–257PubMedCrossRefGoogle Scholar
  243. Walther EU, Seelos K, Bise K, Mayer M, Straube A (2004) Lyme neuroborreliosis mimicking primary CNS lymphoma. Eur Neurol 51: 43–45PubMedCrossRefGoogle Scholar
  244. Wang ZY, Hansen K, Siden A, Cruz M (1993) Intrathecal synthesis of anti-Borrelia burgdorferi antibodies in neuroborreliosis: A study with special emphasis on oligoclonal IgM antibody bands. Scand J Immunol 37: 369–376PubMedCrossRefGoogle Scholar
  245. Weder B, Wiedersheim P, Matter L, Steck A, Otto F (1987) Chronic progressive neurological involvement in Borrelia burgdorferi infection. J Neurol 234: 40–43PubMedCrossRefGoogle Scholar
  246. Weigelt W, Schneider T, Lange R (1992) Sequence homology between spirochaete flagellin and human myelin basic protein. Immunol Today 13: 279–280PubMedCrossRefGoogle Scholar
  247. Weis JJ, Ma Y, Erdile LF (1994) Biological activities of native and recombinant Borrelia burgdorferi outer surface protein A: dependence on lipid modification. Infect Immun 62: 4632–4636PubMedGoogle Scholar
  248. Weise J, Crome O, Sandau R, Schulz-Schaeffer W, Bahr M, Zerr I (2004) Upregulation of cellular prion protein (PrPc) after focal cerebral ischemia and influence of lesion severity. Neurosci Lett 372: 146–150CrossRefGoogle Scholar
  249. Weisfelt M, Beek D van de, Spanjaard L (2008) A risk score for unfavorable outcome in adults with bacterial meningitis. Ann Neurol 63: 90–97PubMedCrossRefGoogle Scholar
  250. Will RG (2003) Acquired prion disease: Iatrogenic CJD, variant CJD, kuru. Br Med Bull 66: 255–265PubMedCrossRefGoogle Scholar
  251. Will RG, Ironside JW, Zeidler M et al. (1996) A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 347: 921–925PubMedCrossRefGoogle Scholar
  252. Will RG, Zeidler M, Stewart GE et al. (2000) Diagnosis of new variant Creutzfeldt-Jakob disease. Ann Neurol 47: 575–582PubMedCrossRefGoogle Scholar
  253. Wilske B (2002) Microbiological diagnosis in Lyme borreliosis. Int J Med Microbiol 291 (Suppl 33): 114–119PubMedCrossRefGoogle Scholar
  254. Wilske B, Steinhuber R, Bergmeister H et al.(1987) Lyme-Borreliose in Süddeutschland. Epidemiologische Daten zum Auftreten von Erkrankungsfallen sowie zur Durchseuchung von Zecken (Ixodes ricinus) mit Borrelia burgdorferi. Dtsch Med Wochenschr 112: 1730–1736PubMedCrossRefGoogle Scholar
  255. Wilske B, Fingerle V, Schulte-Spechtel U (2007) Microbiological and serological diagnosis of Lyme borreliosis. FEMS Immunol Med Microbiol 49: 13–21PubMedCrossRefGoogle Scholar
  256. Windl O, Giese A, Schulz-Schaeffer W et al. (1999) Molecular genetics of human prion diseases in Germany. Hum Genet 105: 244–252PubMedCrossRefGoogle Scholar
  257. Winterholler M, Erbguth FJ (2001) Tick bite induced respiratory failure. Diaphragm palsy in Lyme disease. Intensive Care Med 27: 1095PubMedCrossRefGoogle Scholar
  258. Wokke JH, Gijn J van, Elderson A, Stanek G (1987) Chronic forms of Borrelia burgdorferi infection of the nervous system. Neurology 37: 1031–1034PubMedGoogle Scholar
  259. Wong M, Connolly AM, Noetzel MJ (1999) Poliomyelitis-like syndrome associated with Epstein-Barr virus infection. Pediatr Neurol 20: 235–237PubMedCrossRefGoogle Scholar
  260. Wormser GP, Dattwyler RJ, Shapiro ED et al. (2006) The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: Clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 43: 1089–1134PubMedCrossRefGoogle Scholar
  261. Wroe SJ, Pal S, Siddique D et al. (2006) Clinical presentation and pre-mortem diagnosis of variant Creutzfeldt-Jakob disease associated with blood transfusion: A case report. Lancet 368: 2061–2067PubMedCrossRefGoogle Scholar
  262. Zerr I (2009) Therapeutic trails in human transmissible spongiform encephalopaths: Recent advances and problems to address. Infect Disord Drug Targets 1: 92–99Google Scholar
  263. Zerr I, Poser S (2002) Clinical diagnosis and differential diagnosis of CJD and vCJD. With special emphasis on laboratory tests. APMIS 110: 88–98PubMedCrossRefGoogle Scholar
  264. Zerr I, Pocchiari M, Collins S et al. (2000a) Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt-Jakob disease. Neurology 55: 811–815Google Scholar
  265. Zerr I, Schulz-Schaeffer WJ, Giese A et al. (2000b) Current clinical diagnosis in CJD: Identification of uncommon variants. Ann Neurol 48: 323–329CrossRefGoogle Scholar
  266. Zerr I, Kallenberg K, Summers DM et al. (2009) Updated clinical diagnostic criteria for sporadic CJD incorporating MRI findings. Brain 132: 2659–2668PubMedCrossRefGoogle Scholar
  267. Zhang JR, Hardham JM, Barbour AG, Norris SJ (1997) Antigenic variation in Lyme disease borreliae by promiscuous recombination of VMP-like sequence cassettes. Cell 89: 275–285PubMedCrossRefGoogle Scholar

Weiterführende Literatur

  1. Abdel Razek AA, El-Shamam O, Abdel Wahab N (2009) Magnetic resonance appearance of cerebral cystic echinococcosis: World Health Organization (WHO) classification. Acta Radiol 50: 549–554PubMedCrossRefGoogle Scholar
  2. Andersson CR, Vene S, Insulander M, Lindquist L, Lundkvist A, Günther G (2010) Vaccine failures after active immunisation against tick-borne encephalitis. Vaccine [Epub ahead of print]Google Scholar
  3. Beek D van de, Drake JM, Tunkel AR et al. (2010a) Nosocomial bacterial meningitis. N Engl J Med 14: 146–154CrossRefGoogle Scholar
  4. Beek D van de, Farrar JJ, Gans J de et al. (2010b) Adjunctive dexamethasone in bacterial meningitis: A meta-analysis of individual patients data. Lancet Neurol 9: 254–263CrossRefGoogle Scholar
  5. Beer R, Pfausler B, Schmutzhard E (2009) Management of nosocomial external ventricular drain-related ventriculomeningitis. Neurocrit Care 10: 363–367PubMedCrossRefGoogle Scholar
  6. Beer R, Pfausler B, Schmutzhard E (2010) Infectious intracranial complications in the neuro-ICI patient population. Curr Opin Crit Care 18 (epub ahead of print)Google Scholar
  7. Berlit P, Fedel Ch, Tornow K, Schmiedeck P (1996) Der bakterielle Hirnabszess. Erfahrungen bei 67 Patienten. Fortsch Neurol Psychiatr 64: 297–306CrossRefGoogle Scholar
  8. Bogdahn U, Wildemann B (1994) Chronic meningitis. In: Hacke W (ed) Neuro critical care. Springer, Berlin Heidelberg New York Tokyo, pp 543–550Google Scholar
  9. Boos J, Esiri MM (1986) Viral encephalitis, pathology, diagnosis, and management. Blackwell, OxfordGoogle Scholar
  10. Brandner S, Isenmann S, Raebert A et al. (1996) Normal host prion protein necessary for scrapie-induced neurotoxicity. Nature 379: 339–343PubMedCrossRefGoogle Scholar
  11. Capo V, Despommier DD (1996) Clinical aspects of infection with trichinella spp. Clin Microbiol Rev 9: 47–54PubMedGoogle Scholar
  12. Centers for Disease Control and Prevention (CDC) (2008) Primary amebic meningoencephalitis – Arizona, Florida, and Texas, 2007. MMWR Morb Mortal Wkly Rep 57: 573–577Google Scholar
  13. Darouiche R, Perkins B, Musher D (1990) Levels of rifampin and ciprofloxacin in nasal secretions: Correlation with MIC90 and eradication of nasopharyngeal carriage of bacteria. J Infect Dis 162: 1124–1127PubMedCrossRefGoogle Scholar
  14. Deutsche Neuro-AIDS Arbeitsgemeinschaft/DNAA (2002) Aktuelle Diagnostik und Therapie opportunistischer Hirnerkrankungen bei Aids. DMW 127: 1479–1485CrossRefGoogle Scholar
  15. Diringer H (1996) Creutzfeldt-Jakob disease. Lancet 347: 1332–1333PubMedCrossRefGoogle Scholar
  16. Dondorp A, Nosten F, Stepniewska K, Day N, White N; South East Asian Quinine Artesunate Malaria Trial (SEAQUAMAT) group (2005) Artesunate versus quinine for treatment of severe falciparum malaria: A randomised trial. Lancet 366: 717–725.PubMedCrossRefGoogle Scholar
  17. Eggers C, DNAA (2002) HIV-1 associated encephalopathy and myelopathy. J Neurol 249: 1132–1136PubMedCrossRefGoogle Scholar
  18. Fischer P-A, Enzensberger W (1987) Neurological complications in AIDS. J Neurol 234: 269–279PubMedCrossRefGoogle Scholar
  19. Florance NR, Davis RL, Lam C et al. (2009) Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents. Ann Neurol 66: 11–18PubMedCrossRefGoogle Scholar
  20. Gans J de, Beek D van de (2002) Dexamethasone in adults with bacterial meningitis. N Engl J Med 347: 1549–1556PubMedCrossRefGoogle Scholar
  21. Garau J (2002) Treatment of drugresistant pneumococcal pneumonia. Lancet Infect Dis 2: 404–415PubMedCrossRefGoogle Scholar
  22. García HH, Evans CA, Nash TE et al. (2002) Current consensus guidelines for treatment of neurocysticercosis. Clin Microbiol Rev 15: 747–756PubMedCrossRefGoogle Scholar
  23. Greenlee JE (1995) Subdural empyema. In: Mandell GL, Bennett JE, Dolin R (eds) Infectious diseases. Churchill Livingstone, New York, pp 900–907Google Scholar
  24. Helbok R, Broessner G, Pfausler B, Schmutzhard E (2009) Chronic meningitis. J Neurol 256: 168–175PubMedCrossRefGoogle Scholar
  25. Kastenbauer S, Pfister HW (2003) Pneumococcal meningitis in adults: spectrum of complications and prognostic factors in a series of 87 cases. Brain 126: 1015–1025PubMedCrossRefGoogle Scholar
  26. Kilic T, Elmaci J, Ozek MM, Pamir MN (2002) Utility of transcranial Doppler ultrasonography in the diagnosis and follow up of tuberculous meningitis-related vasculopathy. Childs Nerv Syst 18: 142–146PubMedCrossRefGoogle Scholar
  27. Klein M, Koedel U, Kastenbauer S et al. (2008) Nitrogen and oxygen molecules in menigitis-associated labyrinthitis and hearing impairment. Infection 36: 2–14PubMedCrossRefGoogle Scholar
  28. Komori H, Takagishi T, Otaki E (1992) The efficacy of MR imaging in subdural empyema. Brain Dev 14: 123–125PubMedGoogle Scholar
  29. Koszewski W (1991) Epilepsy following brain abscess. The evaluation of possible risk factors with emphasis on a new concept of epileptic focus formation. Acta Neurochir 113: 110–117CrossRefGoogle Scholar
  30. Kropp S, Finkenstaedt M, Zerr I, Schröter A, Poser S (2000) Diffusion-weighted MRI in patients with Creutzfeldt-Jakob disease. Nervenarzt 71: 91–95PubMedCrossRefGoogle Scholar
  31. Lackner P, Beer R, Broessner G et al. (2010) Acute granulomatous Acanthamoeba encephalitis in an immunocompetent patient. Neurocrit Care 12: 91–94PubMedCrossRefGoogle Scholar
  32. Liu YH, Wang XG, Gao JS, Qingyao Y, Horton J (2009) Continuous albendazole therapy in alveolar echinococcosis: Long-term follow-up observation of 20 cases. Trans R Soc Trop Med Hyg 103: 768–778PubMedCrossRefGoogle Scholar
  33. Lorber B (1997) Listeriosis. Clin Infect Dis 24: 1–9PubMedCrossRefGoogle Scholar
  34. Lu CH, Chang WN, Lin Yc et al. (2002) Bacterial brain abscess: microbiological features, epidemiological trends and therapeutic outcomes. Q J Med 95: 501–509CrossRefGoogle Scholar
  35. Mandell GL, Bennett JE, Dolin R (eds) (1995) Principles and practice of infectious diseases, 4th edn. Churchill Living stone, New YorkGoogle Scholar
  36. Matthaiou DK, Panos G, Adamidi ES, Falagas ME (2008) Albendazole versus Praziquantel in the treatment of neurocysticercosis: A meta-analysis of comparative trials. PLoS Negl Trop Dis 2: e194PubMedCrossRefGoogle Scholar
  37. McCormick GF, Zee CS, Heiden J (1982) Cysticercosis cerebri. Arch Neurol 39: 534–539PubMedGoogle Scholar
  38. McLauchlin J, Grant KA, Little CL (2006) Food-borne botulism in the United Kingdom. J Public Health (Oxf) 28: 337–342CrossRefGoogle Scholar
  39. Memish ZA (2002) Meningococcal disease and travel. Clin Infect Dis 34: 84–90PubMedCrossRefGoogle Scholar
  40. Mishra SK, Wiese L (2009) Advances in the management of cerebral malaria in adults. Curr Opin Neurol 22: 302–307PubMedCrossRefGoogle Scholar
  41. Murray PR, Baron EJ, Pfaller MA, Tenover FC, Jolken RH (eds) (1995) Manual of clinical microbiology, 6th edn. American Society for Microbiology Press, Washington DCGoogle Scholar
  42. Nunez DA, Browning GG (1990) Risks of developing an oto genic intracranial abscess. J Laryngol Otol 104: 468–472PubMedCrossRefGoogle Scholar
  43. Osterholm MT, Hedberg CW, McDonald KL (1995) Epidemiology of infectious diseases. In: Mandell GL, Bennett JE, Dolin R (eds) Infectious diseases. Churchill Livingstone, New York, pp 158–168Google Scholar
  44. Pfausler B, Spiss H, Beer R (2003) Treatment of staphylococcal ventriculitis associated with external cerebrospinal fluid drains: a prospective randomised trial of intravenous compared with intraventricular vancomycin therapy. J Neurosurg 98: 1040–1044PubMedCrossRefGoogle Scholar
  45. Pfister HW (2002) Meningitis. Kohlhammer, StuttgartGoogle Scholar
  46. Pittock SJ, Debruyne J, Krecke KN, Giannini C, van den Ameele J, De Herdt V, McKeon A, Fealey RD, Weinshenker BG, Aksamit AJ, Krueger BR, Shuster EA, Keegan BM (2010) Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS). Brain 133: 2626–2634PubMedCrossRefGoogle Scholar
  47. Prasad K, Karlupia N, Kumar A (2009) Treatment of bacterial meningitis: An overview of Cochrane systematic reviews. Respir Med 103: 945–950PubMedCrossRefGoogle Scholar
  48. Quagliarello VJ, Scheld WM (1992) Bacterial meningitis: pathogenesis, pathophysiology and progress. N Engl J Med 327: 864–872PubMedCrossRefGoogle Scholar
  49. Quagliarello VJ, Scheld WM (1997) Treatment of bacterial meningitis. N Engl J Med 337: 708–716CrossRefGoogle Scholar
  50. Schaad UB, Lips U, Gnehm HE, Blumberg A, Heinzer I, Wedgwood J (1993) Dexamethasone therapy for bacterial meningitis in children. Lancet 342: 457–461PubMedCrossRefGoogle Scholar
  51. Schmutzhard E (2000) Entzündliche Erkrankungen des Nervensystems. Thime, StuttgartGoogle Scholar
  52. Schmutzhard E (2001) Viral infections oft the CNS with special emphasis on herpes simplex infections. J Neurol 248: 469–477PubMedCrossRefGoogle Scholar
  53. Schmutzhard E (2003a) Fungal infections. In: Noseworthy JH (ed) Neurological therapeutics – principles and practice. Dunitz, London New York, pp 972–1002Google Scholar
  54. Schmutzhard E (2003b) Protozoal infections. In: Noseworthy JH (ed) Neurological therapeutics – principles and practice. Dunitz, London New York, pp 1003–1020Google Scholar
  55. Schmutzhard E (2006a) Fungal infections. In: Noseworthy JH (ed) Neurological therapeutics – principles and practice, 2nd edn. Informa Healthcare, Oxon, UK, pp 1085–1115Google Scholar
  56. Schmutzhard E (2006b) Protozoal infections. In: Noseworthy JH (ed) Neurological therapeutics – principles and practice, 2nd edn. Informa Healthcare, Oxon, UK, pp 1116–1132Google Scholar
  57. Schmutzhard E (2010) Parasitäre Erkrankungen des Nervensystems. Nervenarzt 81: 162–171PubMedCrossRefGoogle Scholar
  58. Schmutzhard E, Pfausler B (2008) Infektionen des ZNS beim immunkompetenten Patienten. Nervenarzt 79: 93–112PubMedCrossRefGoogle Scholar
  59. Schmutzhard E, Williams KJ, Vukmirovits G, Chmelik V, Pfausler B, Featherstone A (1995) A randomized comparison of Meropenem with Cefotaxime or Ceftriaxone for the treatment of bacterial meningitis in adults. J Antimicrob Chemother 36: 85–97PubMedGoogle Scholar
  60. Schwartz B (1991) Chemoprophylaxis for bacterial infections: principles of and application to meningococcal infections. Rev Infect Dis 13 (suppl): 170CrossRefGoogle Scholar
  61. Sinha S, Sharma BS (2009) Neurocysticercosis: A review of current status and management. J Clin Neurosci 16: 867–876PubMedCrossRefGoogle Scholar
  62. Sinner SW, Tunkel AR (2002) Approach to the diagnosis and management of tuberculous meningitis. Curr Infect Dis Rep 4: 324–331PubMedCrossRefGoogle Scholar
  63. Skelton R, Maixner W, Isaacs D (1992) Sinusitis-induced subdural empyema. Arch Dis Child 67: 1478–1480PubMedCrossRefGoogle Scholar
  64. Skogberg K, Syrjänen J, Jahkola M (1992) Clinical presentation and outcome of listeriosis in patients with and without immunosuppressive therapy. Clin Infect Dis 14: 815–821PubMedCrossRefGoogle Scholar
  65. Smith TL, Nathan BR (2002) Central nervous system infections in the immune-competent adult. Curr Treat Options Neurol 4: 323–332PubMedCrossRefGoogle Scholar
  66. Spanos A, Harrell FE, Durack DT (1989) Differencial diagnosis of acute meningitis: An analysis of the predictive value of inizial observation. JAMA 262: 2700–2707PubMedCrossRefGoogle Scholar
  67. Spencer MD, Knight RS, Will RG (2002) First hundred cases of variant Creutzfeldt-Jakob disease: retrospective case note review of early psychiatric and neurological features. BMJ 324: 1479–1482PubMedCrossRefGoogle Scholar
  68. Stocksill MT, Kauffman CA (1983) Comparison of cryptococcal and tuberculous meningitis. Arch Neurol 40: 81–85Google Scholar
  69. Swartz M (1987) Chronic meningitis – Many causes to consider. N Engl J Med 317: 957–959PubMedCrossRefGoogle Scholar
  70. Tiecks F, Pfister HW, Ray G (1994) Other viral infections. In: Hacke W (ed) Neuro critical care. Springer, Berlin Heidelberg New York Tokyo, pp 468–492Google Scholar
  71. Tunkel AR, Scheld WM (1995) Acute bacterial meningitis. Lancet 346: 1675–1680PubMedCrossRefGoogle Scholar
  72. Van Everbroeck BR, Boons J, Cras P (2005) 14-3-3(gamma)-isoform detection distinguishes sporadic Creutzfeldt-Jakob disease from other dementias. J Neurol Neurosurg Psychiatry 76: 100–102PubMedCrossRefGoogle Scholar
  73. Vardakas KZ, Matthaiou DK, Falagas ME (2009) Adjunctive dexamethasone therapy for bacterial meningitis in adults: A metaanalysis of randomized controlled trials. Eur J Neuro 16 :662–673CrossRefGoogle Scholar
  74. Wackym PA, Canalis RF, Feuermann T (1990) Subdural empyema of otorhinological origin. J Laryngol Otol 104: 118 –122PubMedCrossRefGoogle Scholar
  75. Wadsworth JD, Asante EA, Desbruslais M et al. (2004) Human prion protein with valine 129 prevents expression of variant CJD phenotype. Science 306: 1793–1796PubMedCrossRefGoogle Scholar
  76. Weber T, Zerr I, Bodemer M, Poser S (1997) Erweitertes Krankheitsspektrum humaner spongiformer Enzephalopathien oder Prionkrankheiten. Nervenarzt 68: 309–323PubMedCrossRefGoogle Scholar
  77. Weisfelt M, Gans J de, Beek D van de (2007) Bacterial meningitis: A review of effective pharmacotherapy. Expert Opin Pharmacother 8: 1493–1504PubMedCrossRefGoogle Scholar
  78. Wilhelm C, Ellner JJ (1986) Chronic meningitis. Neurol Clin 4: 115–141PubMedGoogle Scholar
  79. Wispelwey B, Scheld WM (1995) Brain abscess. In: Mandell GL, Bennett JE, Dolin R (eds) Infectious diseases. Churchill Livingstone, New York, pp 887–900Google Scholar
  80. Yadav P, Sharma R, Kumar S, Kumar U (2008) Magnetic resonance features of cerebral malaria. Acta Radiol 49: 566–569PubMedCrossRefGoogle Scholar
  81. Zerr I, Pocchiari M, Collins S et al. (2000a) Analysis of EEG and CSF 14-3-3 protein as aids to the diagnosis of Creutzfeldt-Jakob disease. Neurology 55: 811–815Google Scholar
  82. Zerr I, Schulz SW, Giese X et al. (2000b) Current clinical diagnosis is Creutzfeldt-Jakob disease: identification of uncommon variants. Ann Neurol 48: 323–329Google Scholar
  83. Zoons E, Weisfeld M, Gans J de et al. (2008) Seizures in adults with bacterial meningitis. Neurology 70: 2109–2115PubMedCrossRefGoogle Scholar
  84. Zungia M, Aguado JM, Vada J (1992) Listeria monocytogenes meningitis in previously healthy adults: Long-term follow-up. QJM 85: 911–915Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2011

Authors and Affiliations

  • E. Schmutzhard
    • 1
  • R. Kaiser
    • 2
  • U. Meyding-Lamadé
    • 3
  • G. Arendt
    • 4
  • T. Nolting
    • 4
  • M. Maschke
    • 5
  • I. Zerr
    • 6
  1. 1.Universitätsklinik für NeurologieUniversität InnsbruckInnsbruckÖsterreich
  2. 2.Klinikum Pforzheim GmbHPforzheim
  3. 3.Krankenhaus NordwestNeurologische KlinikFrankfurt
  4. 4.Klinik für NeurologieHeinrich-Heine-UniversitätDüsseldorf
  5. 5.Klinik für NeurologieBrüderkrankenhausTrier
  6. 6.Neurologische KlinikUniversitätsklinikum GöttingenGöttingen

Personalised recommendations